Chithandizo Chatsopano cha Kunenepa Kwambiri

XW003 ndi analogi, wokhalitsa ngati glucagon-ngati peptide-1 (GLP-1) wopangidwa ku Sciwind Biosciences. Zawonetsedwa kuti ndizotetezeka komanso zolekerera bwino, komanso kuchepetsa kulemera kodalira mlingo m'mayesero oyambirira achipatala.

Mayesero apakati, osasinthika, otseguka, oyendetsedwa bwino a Phase 2b akukonzekera kuyesa kamodzi pa sabata subcutaneous administration ya XW003 pafupifupi odwala 200 omwe ali ndi kunenepa kwambiri. Ochita nawo chiyesocho, chomwe chikuchitika ku Australia ndi New Zealand, adzathandizidwa ndi mankhwala ophunzirira mpaka masabata a 26, ndikutsatiridwa ndi masabata a 5 opanda chithandizo. Cholinga cha phunziroli ndikuwunika chitetezo, kulekerera, ndi mphamvu ya chithandizo cha XW003 mwa odwala onenepa kwambiri. Deta yapamwamba ikuyembekezeredwa mu theka lachiwiri la 2022. Kuphatikiza apo, monga gawo la pulogalamu yonse yachitukuko cha XW003, kuyesa kosiyana kwa odwala achi China omwe ali ndi kunenepa kwambiri kukuchitikanso.

"Ndife okondwa kupitiliza kupita patsogolo kwa XW003 kudzera pakukula kwachipatala. Kukhazikitsidwa kwa dosing kwa odwala m'malo ambiri awa, kafukufuku wapadziko lonse wochizira kunenepa kwambiri ndi chinthu china chofunikira kwambiri kwa kampaniyo komanso umboni wamphamvu wa kudzipereka ndi kuthekera kwa gulu lathu, "atero Dr. Hai Pan, woyambitsa ndi CEO wa Sciwind. "Tadzipereka kupitiliza chitukuko cha XW003, komanso anthu ena omwe akufuna kugwiritsa ntchito mankhwala osokoneza bongo mu pipeline ya Sciwind, pofuna kuchiza matenda a metabolic, kuphatikizapo kunenepa kwambiri, shuga, ndi NASH."